ACCS - Amphora Capital Group Co-Host Banquet 美中企业家商会举办中国医疗投资代表团与企业家，医疗机构专家晚宴聚会

    ACCS - Amphora Capital Group Co-Host Banquet

     Time:  6:00 pm to 9:30 pm January 18th 2017

     Location: THE UNIVERSITY CLUB of PASADENA 企业俱乐部

                          175 N. Oakland Avenue  Pasadena, CA  91101

                           Weili Zhou, President 

                        Amphora Capital Group

               Thomas J. Coates, Ph.D. Director

Dr. Coates is the Director of the UCLA Center for World Health and the UCLA Program in Global Health and is also the Michael and Sue Steinberg Endowed Professor of Global AIDS Research within the Division of Infectious Diseases at UCLA. 

                     Michael Burke, MHA, Director

Michael is the Director of UCLA Health International and Director of Business Development for the UCLA Center for World Health.  

                        Judith Gasson, Ph.D. Director

Judith C. Gasson, a professor of biological chemistry and medicine, became director of UCLA’s Jonsson Comprehensive Cancer Center on Sept. 15, 1995. A molecular biologist, Gasson is responsible for one of only 39 institutions nationwide designated as comprehensive cancer centers by the National Cancer Institute. 

                               Jian Yu Rao, M.D.

Dr. J Rao is a diagnostic surgical/cytopathologist and established investigator in cancer biomarker studies. Prior to be a pathologist, he was already an established molecular epidemiologist involved in multiple high profile cancer prevention studies. He completed his anatomic/clinical pathology residency and cytopathology fellowship at UCLA, and joined the UCLA Department of Pathology as a faculty in 1999.               

     Come to meet 20 member of China Healthcare Investor's Delegation to discuss business opportunity!  

Christopher Moulding, Director

Christopher Moulding is the Associate Director in the Office of Technology Licensing at City of Hope.  Chris has been involved in Tech Transfer for over 25 years, having held licensing positions at UCLA, Caltech, Howard Hughes Medical Institute, and the University of Southern California.  Chris began his career working as a research associate at Harvard Medical School and NIH, and thereafter he earned an MBA from Stanford Business School.  He worked at Genentech, Chiron, and Systemix in business development, and was a co-founder of Recombinant Capital, a financial advisory services company.

Linda Malkas

Ph.D. M.T.  & B.A. Ahmadinia Professor in Molecular Oncology Deputy Director of Basic Research and Co-leader, Women's Cancers Programs, Comprehensive Cancer Center  Professor and Associate Chairman of Molecular and Cellular Biology Linda H. Malkas is currently professor and associate chair of the Department of Molecular and Cellular Biology at the Beckman Research Institute of City of Hope, serving as the deputy director of basic research. In 2011, she co-founded the Molecular Oncology Program at the cancer center. 

Yuan Chen

 Beckman Research Institute of the City of Hope

Professor Chen, graduated from the University of Science and Technology of China in 1985 with a Ph.D. in Chemistry from Rutgers University in 1992. He received his PhD in Chemistry from the University of Science and Technology of China. After completing his postdoctoral work at the laboratory of Peter Wright of the Scripps Research Institute, he began tenure at City of Hope in 1994. Her laboratory focuses on research and discovery of new anti-cancer mechanisms and new drug development. Her research has been supported by research funding from the National Institutes of Health (NIH), which has many years of experience leading research projects to success.

Yong QIAN Ph.D

Dr QIAN is the president of BioMedicure Group,having been a senior scientist of GeneCure and Access Business Group；Dr QIAN received his Ph.D in University and post-Ph.D in University of Kentucky. Dr. Qian has extensive research in the field of new antigenic immunology for genomics, and has obtained many US patents.

Qin PU Ph.D

Dr PU, graduated from the  Nankai University with bachelor degree in chemistry Biology, and from the 4^th Military Medical University with Ph.D in chemistry biology .Working in Biomedical Engineering of Genomics for more than 20 years, having constructed an advanced genetic engineering  platform, his main research areas are gene-based biotechnology, bio-chemical engineering, bioinformatics, Engineering technology platform and the re-understanding of a variety of complex diseases genetic engineering vaccine.

Sanjeev Saxena,  CEO

CEO of POC Medical Systemes ,30 + years of experience in starting and running  companies, engineering, sales，marketing and  business development for medical device and Biotech companies,Founder of Actis Biologics, Telesto Diagnostics (In India  and Malaysia respectively), Co-founder of Scanis, Sepragen Corp .

"Ginnie" Xin Xu, Ph.D.

"Ginnie" Xin Xu, Ph.D. is a Technology Licensing Manager at City of Hope. Ginnie joined City of Hope in 2016. Previously Ginnie has worked at tech transfer offices at University of Southern California and Rutgers University. She holds a Ph.D. from Princeton University in Molecular Biology and Neuroscience; and a B.S. from Fudan University in Life Sciences.

Sincerely,

Viona Zhang 张嘉倩

Project Director 项目总监

American- Chinese CEO Society

vionaaccs@gmail.com

Mobile: 626-466-6833